Acne Treatment Market Insights
Acne is a stubborn skin condition which often needs intensive treatment to clear effectively. The chronic inflammatory condition is common and is often a part of puberty for most individuals, however, for many, the problem can escalate into adulthood with specific factors contributing to the condition.
Acne often leads to depression and reduces the percieved quality of life making treatment highly important. Market Research Future has found that the global market for acne treatment will experience a moderate CAGR of 5.3% during the forecast period of 2017 to 2023.
Increasing awareness about acne, growing expenditure on cosmetic procedures and the availability of various treatment options are some principal drivers of growth for the acne treatment market. Changing lifestyles, increased consumption of unhealthy food and rising cases of hormonal imbalances are indirect causes of acne which subsequently facilitate growth for the acne treatment market.
Request a Premium Sample Report @ https://www.marketresearchfuture.com/sample_request/5675 .
Presently, treatment options are not uniformly effective as acne is sometimes a symptom of a larger underlying cause. Moreover, side effects associated with prescription drugs and safety concerns with generic drugs are expected to hinder growth. However, ongoing development of treatment options and the high demand for effective and cost-efficient acne treatment products and services will offer new opportunities in the coming years.
Acne Treatment Market Segmentation
The global acne treatment market has been broadly segmented based on type, treatment, treatment modality, end users, and region.
By treatment, the market has been divided to include medication, therapeutic devices, and others. Further sub-segmentation includes:
- Medication – retinoid, antibiotics, and others
- Retinoid – adapalene, tretinoin, and others
- Antibiotics – erythromycin, clindamycin, and others.
- Therapeutic devices – lasers, microdermabrader, dermabradors and others
By treatment modality, the market has been segregated into oral, topical and injectable.
By end users, the market has been categorized into hospitals & clinics, pharmacies & drug stores, ambulatory surgical centers, and others.
By region, the global market has been divided into the Americas, Europe, Asia Pacific, and the Middle East & Africa.
Acne Treatment Market Regional Analysis
The Americas include both North and South America. Of these, North America includes developed countries such as U.S and Canada; it is these economies that have driven the robust growth of the market in this region. A well-established healthcare sector, the existence of a wide patient population who are increasingly demanding effective and affordable treatment options are some other drivers of growth in the region.
Europe, with its increasing teenage population, has the second largest market share. Other factors that contribute to market growth include the availability of research funds and a large patient population
The Asia-Pacific is anticipated to grow at the highest CAGR due to increasing occurrence of acne in the region. Developing economies like India and China include vast populations who are steadily growing aware of various treatment options and are shifting from a primarily traditional approach to acne treatment are affecting market growth further. The region has a growing healthcare sector and a high demand for modern treatment alternatives.
The Middle East & Africa possesses the smallest market share which is primarily due to the presence of impoverished countries in Africa where basic healthcare needs are still being met. However, projected growth for this region is expected from developing countries in the Middle East such as Saudi Arabia, U.A.E and Kuwait thus facilitating limited growth.
Acne Treatment Market Key Players
Several key players have been identified and profiled extensively in the report, including Teva Pharmaceutical Industries Ltd., Allergan, Stiefel Laboratories, Inc., Galderma S.A., Johnson & Johnson Services, Inc., GlaxoSmithKline Plc., Valeant, Roche Holding AG, and Bayer AG among others.
Latest Acne Treatment Industry News
Zydus Cadila has just received USFDA approval to sell Doxycycline Hyclate capsules USP. This capsule is a tetracycline antibiotic and is effective in the treatment of a variety of bacterial infections including those that cause acne. They will be available in 50mg and 100mg.
Researchers at the University of Pennsylvania have found that Spironolactone, a well known diuretic drug, may be an effective solution for acne treatment for women.
Ask to Experts @ https://www.marketresearchfuture.com/enquiry/5675 .
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Company Name: Market Research Future
Contact Person: Abhishek Sawant
Email: Send Email
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar